上海上药第一生化药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
225
NMPA:225
Drug Approvals
Dobutamine Hydrochloride Injection
- Product Name
- 盐酸多巴酚丁胺注射液
- Approval Number
- 国药准字H20258013
- Approval Date
- Jan 26, 2025
NMPA
Amiodarone Hydrochloride Injection
- Product Name
- 盐酸胺碘酮注射液
- Approval Number
- 国药准字H20243204
- Approval Date
- Feb 23, 2024
NMPA
Lacosamide Oral Solution
- Product Name
- 拉考沙胺口服溶液
- Approval Number
- 国药准字H20234264
- Approval Date
- Oct 12, 2023
NMPA
Bivalirudin for Injection
- Product Name
- 注射用比伐芦定
- Approval Number
- 国药准字H20233081
- Approval Date
- Jan 19, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
Clinical Trials
No trials found
News
No news found